Li Yishan
Insider CIK 1772233 · BLSM Executive Chairman, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 124,779 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,600,682 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 113,435 | — | $0 | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,600,682 | — | $0 | 1,600,682 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 124,779 | — | $0 | 124,779 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 113,435 | — | $0 | 1,714,117 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 124,779 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 113,435 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion deriv | 2026-08-10 | 2026-08-10 | 1,600,682 | — | — | 0 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 124,779 | — | — | 124,779 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 113,435 | — | — | 1,714,117 | SEC↗ |
| BLSM BlossomHill Therapeutics, | C Conversion | 2026-08-10 | 2026-08-10 | 1,600,682 | — | — | 1,600,682 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 112,701 | — | $0 | 112,701 | SEC↗ |
| BLSM BlossomHill Therapeutics, | A Award deriv | 2026-08-06 | 2026-08-10 | 112,701 | — | $0 | 112,701 | SEC↗ |